News
News

News

11/10/2020 STRATA Skin Sciences Reports Third Quarter 2020 Financial Results

STRATA Skin Sciences Reports Third Quarter 2020 Financial Results

HORSHAM, Pa. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today
11/05/2020 STRATA Skin Sciences to Present at Three Upcoming Investor Conferences

STRATA Skin Sciences to Present at Three Upcoming Investor Conferences

HORSHAM, Pa. , Nov. 05, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today
11/03/2020 STRATA Skin Sciences to Report Third Quarter 2020 Financial Results on November 10, 2020

STRATA Skin Sciences to Report Third Quarter 2020 Financial Results on November 10, 2020

HORSHAM, Pa. , Nov. 03, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
11/02/2020 STRATA Skin Sciences’ XTRAC® Technology Found to Be Most Effective and Most Economical Treatment for Plaque Psoriasis Compared to Other Therapies

STRATA Skin Sciences’ XTRAC® Technology Found to Be Most Effective and Most Economical Treatment for Plaque Psoriasis Compared to Other Therapies

Delivers fastest results with fewest adverse events   compared to topical, traditional UV, biologic and systemic therapies   Providing a better solution for I ntegrated H ealth S ystems and Capitation healthcare – managing the patients and reducing costs for chronic skin disease  Up to 97% savings
10/19/2020 STRATA Skin Sciences Announces: Expanding Medical Coverage for Excimer Laser Treatment of Dermatological Conditions, Enlarging Company’s Addressable Market

STRATA Skin Sciences Announces: Expanding Medical Coverage for Excimer Laser Treatment of Dermatological Conditions, Enlarging Company’s Addressable Market

Cigna Now Provides Insurance Coverage of Excimer Laser Therapy for the treatment of Vitiligo HORSHAM, Pa. , Oct. 19, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: SSKN) STRATA Skin Sciences, Inc. (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing,
10/06/2020 STRATA Skin Sciences to Participate in the MicroCap Rodeo Best Ideas Bowl

STRATA Skin Sciences to Participate in the MicroCap Rodeo Best Ideas Bowl

HORSHAM, PA / ACCESSWIRE / October 6, 2020 / STRATA Skin Sciences (NASDAQ:SSKN) ("STRATA") a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that
09/14/2020 STRATA Skin Sciences Announces New Recurring Revenue Direct Distribution Contract with JMEC Co., Ltd. in Japan

STRATA Skin Sciences Announces New Recurring Revenue Direct Distribution Contract with JMEC Co., Ltd. in Japan

Company expanding global presence and introducing recurring business model in Japan HORSHAM, Pa. , Sept. 14, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN)  (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and
09/08/2020 STRATA Skin Sciences to Present at Two Upcoming Investor Conferences

STRATA Skin Sciences to Present at Two Upcoming Investor Conferences

HORSHAM, Penn. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today
08/11/2020 STRATA Skin Sciences Reports Second Quarter 2020 Financial Results

STRATA Skin Sciences Reports Second Quarter 2020 Financial Results

Recurring revenue for the second quarter of 2020 was $2.8 million , a 52.1% decrease over second quarter 2019 Total gross margins in the second quarter of 2020 was 48.7%, a 14.9% decrease over second quarter 2019 Global recurring revenue installed base totaled 806 systems at June 30, 2020
08/04/2020 STRATA Skin Sciences to Host Second Quarter 2020 Financial Results and Business Update Conference Call on August 11

STRATA Skin Sciences to Host Second Quarter 2020 Financial Results and Business Update Conference Call on August 11

HORSHAM, Pa. , Aug. 04, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic